502 results
Keyword Indapamide Sandoz Remove keyword
-
List item
Withdrawn application: Duloxetine Sandoz
duloxetine, date of withdrawal: 08/04/2015, Initial authorisation, Last updated: 24/04/2015Duloxetine Sandoz: Withdrawn application … Duloxetine Sandoz: Withdrawal of the marketing … application for Duloxetine Sandoz (duloxetine) On 08 April … -
List item
Human medicine European public assessment report (EPAR): Corbilta (previously Levodopa/Carbidopa/Entacapone Sandoz)
levodopa, carbidopa, entacapone, Parkinson Disease
Date of authorisation: 11/11/2013, Revision: 10, Authorised, Last updated: 16/01/2023Levodopa/Carbidopa/Entacapone Sandoz) Nervous System Diseases Neurodegenerative … Levodopa/Carbidopa/Entacapone Sandoz) : EPAR - All Authorised presentations … Levodopa/Carbidopa/Entacapone Sandoz) : EPAR - Procedural steps … -
List item
Human medicine European public assessment report (EPAR): Temozolomide Sandoz
temozolomide, Glioma; Glioblastoma
Date of authorisation: 15/03/2010,
, Revision: 17, Withdrawn, Last updated: 06/03/2023
Temozolomide Sandoz Cancer Neuroectodermal … Temozolomide Sandoz … statement Temozolomide Sandoz (temozolomide) Withdrawal … -
List item
Human medicine European public assessment report (EPAR): Pregabalin Sandoz
pregabalin, Anxiety Disorders; Neuralgia; Epilepsy
Date of authorisation: 19/06/2015,, Revision: 15, Authorised, Last updated: 05/01/2023
Pregabalin Sandoz Mental Disorders Nervous … report (EPAR) for Pregabalin Sandoz. It explains how the Agency … on how to use Pregabalin Sandoz. For practical information … -
List item
Human medicine European public assessment report (EPAR): Rivastigmine Sandoz
rivastigmine, Dementia; Alzheimer Disease; Parkinson Disease
Date of authorisation: 10/12/2009, Revision: 13, Authorised, Last updated: 13/10/2022Rivastigmine Sandoz Nervous System Diseases Central … EPAR). What is Rivastigmine Sandoz? Rivastigmine Sandoz is a medicine containing … be used for Rivastigmine Sandoz (‘informed consent’ … -
List item
Human medicine European public assessment report (EPAR): Aripiprazole Sandoz
aripiprazole, Schizophrenia; Bipolar Disorder
Date of authorisation: 20/08/2015,, Revision: 9, Authorised, Last updated: 01/09/2022
Aripiprazole Sandoz Schizophrenia Spectrum and … Aripiprazole Sandoz … Aripiprazole Sandoz EPAR summary 30 … -
List item
Human medicine European public assessment report (EPAR): Clopidogrel Sandoz
clopidogrel, Peripheral Vascular Diseases; Stroke; Myocardial Infarction
Date of authorisation: 21/09/2009,, Revision: 2, Withdrawn, Last updated: 26/10/2011
Clopidogrel Sandoz Peripheral Vascular Diseases Stroke Myocardial … Clopidogrel Sandoz … Clopidogrel Sandoz (clopidogrel) Withdrawal … -
List item
Human medicine European public assessment report (EPAR): Pregabalin Sandoz GmbH
pregabalin, Anxiety Disorders; Epilepsy
Date of authorisation: 19/06/2015,, Revision: 14, Authorised, Last updated: 05/01/2023
Pregabalin Sandoz GmbH Mental Disorders Nervous … report (EPAR) for Pregabalin Sandoz GmbH. It explains how the … on how to use Pregabalin Sandoz GmbH. For practical information … -
List item
Human medicine European public assessment report (EPAR): Pemetrexed Sandoz
pemetrexed disodium hemipentahydrate, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 18/09/2015,, Revision: 7, Authorised, Last updated: 27/07/2022
Pemetrexed Sandoz Carcinoma, Bronchogenic Bronchial … Pemetrexed Sandoz … for the public Pemetrexed Sandoz pemetrexed This is a summary … -
List item
Human medicine European public assessment report (EPAR): Ibandronic Acid Sandoz
ibandronic acid, Breast Neoplasms; Neoplasm Metastasis; Fractures, Bone
Date of authorisation: 26/07/2011,, Revision: 9, Authorised, Last updated: 06/07/2022
Ibandronic Acid Sandoz Skin and Connective Tissue … EPAR) for Ibandronic Acid Sandoz. It explains how the Committee … of use for Ibandronic Acid Sandoz. What is Ibandronic Acid Sandoz? Ibandronic Acid Sandoz is a medicine that contains … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): Ramipril, Indapamide
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Cardiovascular diseases
PIP number: EMEA-002081-PIP01-16, Route(s) of administration: Oral use, Pharmaceutical form(s): Modified-release tablet
Decision date: 05/05/2017, Last updated: 04/07/2017, Compliance check: XActive substance Ramipril Indapamide Therapeutic area Cardiovascular … specific waiver for ramipril / indapamide (EMEA-002081-PIP01-16) in … specific waiver for ramipril / indapamide (EMEA-002081-PIP01-16) in … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): valsartan, Indapamide
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Cardiovascular diseases
PIP number: EMEA-001377-PIP01-12, Route(s) of administration: Oral use, Pharmaceutical form(s): Film-coated tablet, Prolonged-release tablet
Decision date: 27/02/2013, Last updated: 23/04/2013, Compliance check: XActive substance valsartan Indapamide Therapeutic area Cardiovascular … specific waiver for valsartan / indapamide (EMEA-001377-PIP01-12 … specific waiver for valsartan / indapamide (EMEA-001377-PIP01-12) in … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): Indapamide, Telmisartan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Cardiovascular diseases
PIP number: EMEA-003151-PIP01-21, Route(s) of administration: Oral use, Pharmaceutical form(s): Modified-release tablet
Decision date: 13/04/2022, Last updated: 19/04/2023, Compliance check: XKey facts Indapamide Telmisartan Cardiovascular … waiver for telmisartan / indapamide (EMEA-003151-PIP01-21) PDF … waiver for telmisartan / indapamide (EMEA-003151-PIP01-21) in … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): Telmisartan, Indapamide
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Cardiovascular diseases
PIP number: EMEA-002462-PIP01-18, Route(s) of administration: Oral use, Pharmaceutical form(s): Tablet
Decision date: 11/01/2019, Last updated: 26/04/2019, Compliance check: XActive substance Telmisartan Indapamide Therapeutic area Cardiovascular … Telmisartan Indapamide … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): perindopril, Indapamide, amlodipine
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Cardiovascular diseases
PIP number: EMEA-001355-PIP01-12, Route(s) of administration: Oral use, Pharmaceutical form(s): Tablet
Decision date: 27/02/2013, Last updated: 23/04/2013, Compliance check: XActive substance perindopril Indapamide amlodipine Therapeutic area … waiver for perindopril / indapamide / amlodipine (EMEA-001355-PIP01-12 … waiver for perindopril / indapamide / amlodipine (EMEA-001355- PIP01-12 … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): perindopril, Indapamide, amlodipine
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Cardiovascular diseases
PIP number: EMEA-001358-PIP01-12, Route(s) of administration: Oral use, Pharmaceutical form(s): Tablet
Decision date: 22/01/2013, Last updated: 03/04/2013, Compliance check: XActive substance perindopril Indapamide amlodipine Therapeutic area … waiver for perindopril / indapamide / amlodipine (EMEA-001358- PIP01-12 … waiver for perindopril / indapamide / amlodipine (EMEA-001358- PIP01-12 … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): perindopril, Indapamide, amlodipine
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Cardiovascular diseases
PIP number: EMEA-001337-PIP01-12, Route(s) of administration: Oral use, Pharmaceutical form(s): Tablet
Decision date: 20/11/2012, Last updated: 04/01/2013, Compliance check: XActive substance perindopril Indapamide amlodipine Therapeutic area … waiver for perindopril / indapamide / amlodipine (EMEA-001337-PIP01-12 … waiver for perindopril / indapamide / amlodipine (EMEA-001337- PIP01-12 … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): Indapamide, Amlodipine besilate
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Cardiovascular diseases
PIP number: EMEA-000896-PIP01-10, Route(s) of administration: Oral use, Pharmaceutical form(s): Tablet
Decision date: 27/08/2010, Last updated: 06/10/2010, Compliance check: XActive substance Indapamide Amlodipine besilate Therapeutic … Decision Amlodipine besilate, Indapamide 7 Westferry Circus ● … product specific waiver for indapamide / amlodipine besilate, (EMEA-000896- PIP01-10 … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): Indapamide, Perindopril erbumine, Amlodipine besilate
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Cardiovascular diseases
PIP number: EMEA-001948-PIP01-16, Route(s) of administration: Oral use, Pharmaceutical form(s): Tablet
Decision date: 09/09/2016, Last updated: 27/10/2016, Compliance check: XActive substance Indapamide Perindopril erbumine Amlodipine … perindopril (erbumine) /indapamide (EMEA-001948-PIP01-16 … perindopril (erbumine) / indapamide (EMEA-001948-PIP01-16) in … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): perindopril arginine, Indapamide, Amlodipine besilate
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Cardiovascular diseases
PIP number: P/17/2011, Route(s) of administration: Oral use, Pharmaceutical form(s): Tablet
Decision date: 21/01/2011, Last updated: 24/02/2011, Compliance check: Xsubstance perindopril arginine Indapamide Amlodipine besilate Therapeutic … for perindopril arginine / indapamide / amlodipine besilate (EMEA-001048-PIP01-10 … for perindopril arginine / indapamide / amlodipine besilate (EMEA-001048-PIP01-10 … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): Amlodipine besilate, Indapamide, perindopril arginine
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Cardiovascular diseases
PIP number: EMEA-002849-PIP01-20, Route(s) of administration: Oral use, Pharmaceutical form(s): Tablet
Decision date: 04/12/2020, Last updated: 20/09/2021, Compliance check: Xsubstance Amlodipine besilate Indapamide perindopril arginine Therapeutic … for amlodipine (besilate)/ indapamide/ perindopril (arginine) (EMEA-002849-PIP01-20 … for amlodipine (besilate)/ indapamide/ perindopril (arginine) (EMEA-002849-PIP01-20 … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): amlodipine, atorvastatin, Indapamide, perindopril arginine
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Cardiovascular diseases
PIP number: EMEA-003173-PIP01-21, Route(s) of administration: Oral use, Pharmaceutical form(s): Capsule, hard
Decision date: 20/05/2022, Last updated: 10/05/2023, Compliance check: Xsubstance amlodipine atorvastatin Indapamide perindopril arginine Therapeutic … perindopril (arginine) / indapamide / amlodipine (EMEA-003173-PIP01-21 … perindopril (arginine) / indapamide / amlodipine (EMEA-003173-PIP01-21 … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): Indapamide, Rosuvastatin, perindopril tert-butylamine
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Cardiovascular diseases; Endocrinology-Gynaecology-Fertility-Metabolism
PIP number: EMEA-001771-PIP01-15, Route(s) of administration: Oral use, Pharmaceutical form(s): Film-coated tablet
Decision date: 04/09/2015, Last updated: 11/12/2018, Compliance check: XActive substance Indapamide Rosuvastatin perindopril … Indapamide Rosuvastatin perindopril … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): Indapamide, perindopril (arginine), amlodipine, bisoprolol (fumarate)
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Cardiovascular diseases
PIP number: EMEA-003015-PIP01-21, Route(s) of administration: Oral use, Pharmaceutical form(s): Capsule, hard
Decision date: 08/09/2021, Last updated: 11/01/2023, Compliance check: XActive substance Indapamide perindopril (arginine) amlodipine … product specific waiver for indapamide / perindopril (arginine … product specific waiver for indapamide / perindopril (arginine … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): atorvastatin (calcium trihydrate), Indapamide, perindopril arginine
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Cardiovascular diseases
PIP number: EMEA-002395-PIP01-18, Route(s) of administration: Oral use, Pharmaceutical form(s): Capsule, hard
Decision date: 08/10/2018, Last updated: 29/01/2019, Compliance check: Xatorvastatin (calcium trihydrate) Indapamide perindopril arginine Therapeutic … statin (calcium trihydrate) Indapamide perindopril arginine …